XML 242 R185.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Provisions, income tax liabilities and other liabilities - Current Provisions and Other Current Liabilities (Details) - EUR (€) € in Millions | 12 Months Ended |
--- | --- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2020 | Dec. 31, 2021
Provisions And Other Current And Non-Current Liabilities [Line Items] |  |  |  |  |  |  |  |
Taxes payable, other than corporate income taxes |  | € 437 | € 395 |  | € 420 |  |  |
Employee-related liabilities |  | 1,929 | 2,106 |  | 2,158 |  |  |
Restructuring provisions (see Note D.19.2.) |  | 653 | 578 |  | 472 |  |  |
Interest rate derivatives (see Note D.20.) |  | 7 | 1 |  | 0 |  |  |
Currency derivatives (see Note D.20.) |  | 330 | 126 |  | 94 |  |  |
Equity derivatives (see Note D.20.) |  | 0 | 0 |  | 0 |  |  |
Amounts payable for acquisitions of non-current assets |  | 878 | 945 |  | 714 |  |  |
Customer contract liabilities | [1] | 0 | 0 |  | 269 |  |  |
Other current liabilities | [2],[3] | 10,007 | 9,590 |  | 7,894 |  |  |
Total |  | 14,241 | 13,741 |  | 12,021 |  |  |
Other revenues |  | 3,205 | 3,801 | [4],[5] | 2,910 | [4],[5] |  |
Contract liabilities |  |  | € 269 |  |  |  |  |
US legal restructuring |  |  |  |  |  |  |  |
Provisions And Other Current And Non-Current Liabilities [Line Items] |  |  |  |  |  |  |  |
Percentage of capital losses used |  |  |  |  |  |  | 33.33% |
Collaboration agreement with GSK |  |  |  |  |  |  |  |
Provisions And Other Current And Non-Current Liabilities [Line Items] |  |  |  |  |  |  |  |
Customer contract liabilities |  |  |  |  | € 269 |  |  | € 319
Direct royalty agreement with SOBI on sales of BeyfortusTM in the United States |  |  |  |  |  |  |  |
Provisions And Other Current And Non-Current Liabilities [Line Items] |  |  |  |  |  |  |  |
Other current liabilities |  | 290 |  |  |  |  |  |
Royalties, payable |  | € 273 |  |  |  |  |  |
[1] | (a)See Note A.5., “Agreements relating to the recombinant COVID-19 vaccine candidate developed by Sanofi in collaboration with GSK”. The year-on-year change in this item between 2023 and 2022 includes revenue of €269 million recognized in profit or loss during 2023 (previously included in “Customer contract liabilities” as of December 31, 2022).
[2] | (c)As of December 31, 2024 includes €273 million (nominal value: €290 million) for the current liability relating to royalties payable to Sobi on net sales of Beyfortus (nirsevimab) in the United States (see Note C.2.)
[3] | (b)“Other current liabilities” mainly comprises provisions and liabilities for customer rebates and returns; provisions for discounts and rebates granted to healthcare authorities and governmental programs (see Note D.23.); and the liability payable at each reporting date under the Monoclonal Antibody Alliance with Regeneron.
[4] | Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation
[5] | (a)Figures for comparative periods (2023 and 2022) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.

X
- Definition The amount of an entity’s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2023-01-01 -Paragraph 105 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2023-01-01 -Paragraph 116 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ContractLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current contract liabilities. [Refer: Contract liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2023-01-01 -Paragraph 105 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_CurrentContractLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 78 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_OtherCurrentLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_OtherRevenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 78 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ShorttermEmployeeBenefitsAccruals
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current provision for restructuring. [Refer: Restructuring provision] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 37 -IssueDate 2023-01-01 -Paragraph 70 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ShorttermRestructuringProvision
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amounts payable for acquisitions of non-current assets. + References No definition available. + Details
Name: | sny_AmountsPayableForAcquisitionOfNonCurrentAssets
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Capital Losses Used Against Capital Gains, Percentage + References No definition available. + Details
Name: | sny_CapitalLossesUsedAgainstCapitalGainsPercentage
Namespace Prefix: | sny_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Currency derivatives. + References No definition available. + Details
Name: | sny_CurrentCurrencyDerivativesPayable
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Current Equity Derivatives Payable + References No definition available. + Details
Name: | sny_CurrentEquityDerivativesPayable
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Current interest rate derivatives payable. + References No definition available. + Details
Name: | sny_CurrentInterestRateDerivativesPayable
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note. + References No definition available. + Details
Name: | sny_CurrentProvisionsAndOtherCurrentLiabilities
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Provisions and other current and non-current liabilities. + References No definition available. + Details
Name: | sny_ProvisionsAndOtherCurrentAndNonCurrentLiabilitiesLineItems
Namespace Prefix: | sny_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties, Payable + References No definition available. + Details
Name: | sny_RoyaltiesPayable
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=sny_USLegalRestructuringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sny_TypesOfAgreementAxis=sny_CollaborationAgreementWithGSKMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sny_TypesOfAgreementAxis=sny_RoyaltyAgreementWithSOBIOnSalesOfBeyfortusInTheUSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |